Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 3 | 2013 | 157 | 0.200 |
Why?
|
| Carcinoma, Lobular | 1 | 2014 | 26 | 0.110 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2014 | 27 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 45 | 0.110 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2013 | 4 | 0.100 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2013 | 46 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 152 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2013 | 77 | 0.090 |
Why?
|
| Mammography | 1 | 2014 | 290 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 321 | 0.090 |
Why?
|
| Hippocalcin | 1 | 2009 | 2 | 0.080 |
Why?
|
| Caudate Nucleus | 1 | 2009 | 25 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1213 | 0.060 |
Why?
|
| Butyrates | 1 | 2003 | 16 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2003 | 36 | 0.050 |
Why?
|
| Neurons | 1 | 2009 | 934 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2003 | 147 | 0.040 |
Why?
|
| Survival Rate | 2 | 2014 | 859 | 0.030 |
Why?
|
| Rats | 2 | 2013 | 2005 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2177 | 0.030 |
Why?
|
| New York | 1 | 2014 | 143 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2014 | 99 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 529 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 187 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 1769 | 0.020 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2009 | 3 | 0.020 |
Why?
|
| Neuronal Apoptosis-Inhibitory Protein | 1 | 2009 | 2 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2009 | 22 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1561 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 575 | 0.020 |
Why?
|
| Lentivirus | 1 | 2009 | 67 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2009 | 72 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2482 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2009 | 101 | 0.020 |
Why?
|
| Female | 4 | 2014 | 33383 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 582 | 0.020 |
Why?
|
| Kidney | 1 | 2009 | 455 | 0.020 |
Why?
|
| Animals | 3 | 2013 | 20955 | 0.020 |
Why?
|
| Mitochondria | 1 | 2009 | 383 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 10994 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 17923 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 5528 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 4782 | 0.010 |
Why?
|
| Nitro Compounds | 1 | 2003 | 15 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2003 | 21 | 0.010 |
Why?
|
| Propionates | 1 | 2003 | 24 | 0.010 |
Why?
|
| Acetylation | 1 | 2003 | 123 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 1552 | 0.010 |
Why?
|
| Body Weight | 1 | 2003 | 379 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 869 | 0.010 |
Why?
|
| Motor Activity | 1 | 2003 | 346 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 851 | 0.010 |
Why?
|
| Histones | 1 | 2003 | 486 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2003 | 1297 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 1223 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 14663 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 17136 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 2237 | 0.010 |
Why?
|
| Humans | 2 | 2014 | 64272 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 1581 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 5696 | 0.010 |
Why?
|
| Male | 1 | 2009 | 30322 | 0.000 |
Why?
|